Winona makes several hormone formats visible in its public catalog, which gives a prospective patient something concrete to investigate. The service describes compounded body and vaginal creams, oral options and an estrogen patch offering.
The central decision is whether the actual prescription is suitable for your needs. A large menu is not a reason to prefer a more complex hormone combination, and a convenient delivery format does not resolve questions about evidence or uterine protection.
In this entry
The catalog is a starting point
The treatment page groups options by route, while the product catalog names individual offerings. Read both carefully: a general category page may describe possibilities more broadly than the product a clinician ultimately prescribes. Ask for the exact formula and do not assume that every hormone mentioned is available in every route.
Winona uses the word bioidentical extensively. That word describes molecular similarity to hormones the body makes. It does not distinguish an FDA-approved estradiol medicine from a customized preparation. For that distinction, ask about the finished prescription’s approval status. The approved-versus-compounded brief explains why it matters.
The price record
The catalog displayed estrogen body cream with progesterone from $89 per month, progesterone capsules from $39 and an estrogen patch from $149 when checked. These are product-specific advertised starting prices. A clinician may propose more than one item, and the amount charged per shipment may not be the same as the monthly figure.
Request the first payment, supply duration, refill price and cancellation deadline together. Ask whether the quote changes if the prescription is adjusted and what happens if treatment is not prescribed. Put those details in the cost worksheet before comparing Winona with a clinic that charges by appointment.
The intake record
Winona says clinicians use medical history and symptoms to assess treatment and that prescription changes go through the treating doctor. It states that routine blood or saliva hormone testing is not required for its HRT plans. For typical menopause assessment, a fluctuating hormone measurement is not automatically more informative than the clinical history.
That statement should not be stretched into a rule that no patient needs testing. Early symptoms, unusual bleeding, other conditions or a different medicine may require another evaluation. Ask how the service identifies those situations and how an in-person referral is coordinated.
The compounded-cream question
A cream can seem appealing if swallowing pills is inconvenient. But for a patient using systemic estrogen who still has a uterus, the plan must reliably address endometrial protection. Ask the clinician what supports the progesterone route and regimen in the proposed plan. A product that combines hormones in one container is not automatically equivalent to separately studied products.
ACOG advises against routine compounded menopause therapy when approved options meet the patient’s needs. If a compounded product is selected, ask what individual problem it solves. Evidence about an ingredient cannot automatically establish the absorption, potency or effects of a different finished preparation.
The follow-up record
Before joining, ask when symptoms will be reviewed, how dose-change requests are handled and which concerns require examination. A written plan should distinguish expected side effects from problems that need prompt attention. Bleeding after menopause should not be waved away solely because hormones were recently started.
Also ask about travel, refill delays and medication changes. An online service may save a pharmacy trip while still requiring active coordination. The ability to send a message is useful; knowing who reads it and how your care continues is more useful.
Where it sits in a comparison
Winona is a documented option for a conversation about compounded menopause formulations. It is not proof that compounding is the preferred next step. Alloy offers an approved-patch comparison, and Gennev offers a visit-centered comparison. Those alternatives help separate treatment preferences from service preferences.
Our review does not score product quality or claim to represent a patient experience. We inspected public material and compared its claims with primary medical guidance. We did not buy medicine, validate fulfillment, audit the pharmacies or independently establish a symptom-relief rate.
A decision you can explain back
Before paying, you should be able to name the treatment target, the medicine, the reason for the route, the complete cost and the next review date. If any of those is unclear, take the question back to the clinician. The online-care checklist helps keep that conversation focused.
CHECK THE ORIGINAL
The source record
Provider pages document their own offers. Medical and regulatory sources provide treatment context. This is not a record of personal patient testing. All sources checked September 20, 2026.